
Monday, June 14, 2021 6:07:09 PM

Liked By
Spread the love. Be the first to like this post!
Recent ENOB News
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:02:10 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:02:02 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:59 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:57 PM
- Statement of Beneficial Ownership (sc 13d) • Edgar (US Regulatory) • 05/19/2023 09:01:56 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:54 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:53 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:52 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:51 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:48 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:44 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:43 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 05/19/2023 09:01:43 PM
- Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 05/16/2023 08:35:15 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 05/12/2023 09:27:50 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 05/05/2023 02:37:31 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/04/2023 08:08:35 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 04/03/2023 01:21:25 PM
- Enochian BioSciences’ CEO Letter to Shareholders • GlobeNewswire Inc. • 04/03/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/29/2023 01:16:07 PM
- Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher • GlobeNewswire Inc. • 03/29/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 01:01:08 PM
- Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements • GlobeNewswire Inc. • 03/13/2023 12:30:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 03/09/2023 09:17:13 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 03/07/2023 01:32:52 PM
CGrowth Capital Consolidates Lithium Tenement Portfolio in Tanzania Amid Renewed Mining Confidence • CGRA • May 25, 2023 11:05 AM
Interactive Strength Inc. d/b/a FORME Launches European Expansion Plan by Focusing on Strategic Partnership with SIGNA Sports United • TRNR • May 24, 2023 10:14 AM
Nextech3D.ai Game-Changing Generative-AI CAD 3D Design Studio Toggle3D.ai Primed For $7 Million June IPO • NTAR • May 24, 2023 10:00 AM
Kaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A. • KAYS • May 24, 2023 9:48 AM
ILUS Confirms Its First Quarter of 2023 Results • ILUS • May 23, 2023 9:34 AM
SKYX Set to Join Russell 2000® and Russell 3000® Indexes • SKYX • May 23, 2023 8:56 AM